Elevated ALS levels in MASLD patients with advanced fibrosis suggest a potential compensatory response to altered IGF signaling, contributing to extracellular matrix deposition and fibrotic progression. This evidence concerns the gene IGF1 and amyotrophic lateral sclerosis.